DOT1L shapes ncPRC1-target gene repression to maintain cell identity of DLBCL [RNA-Seq]
RNA-seq (gene expression) · human · 24 samples
- What it is
- RNA-seq (gene expression)Gene activity measured by sequencing. The summary does not mention single-cell work, so this is most likely bulk: one average per sample, the usual starting point for comparing groups.
- Organism
- Homo sapiens (human)
- Topic
- Diffuse large B-cell lymphomaThis series is part of our curated briefing on it.
- Samples
- 24 samples: 8 conditions, mostly in triplicateGroups are read from the sample names, not from the paper. Check the list below.
- Data you can get
- A processed table (series matrix) and supplementary files from NCBI; the raw sequencing reads from ENA. Which of these hold counts depends on the study, so check the file list.
Read the full summary ↓
Direct links to NCBI and ENA, no account and no request form. Pick by what you want to do: take the small processed table to look, the supplementary files to re-analyse, or the original raw data to start over.
Processed table
The series matrix: one table of values per sample as the submitters processed it. The smallest download, and it opens in Excel or R. Start here to see what the data look like.
Supplementary files
The count tables and other files the authors uploaded. Take only the samples you need, or the whole study as GSE327307_RAW.tar (it can run to tens of gigabytes).
Raw sequencing reads
The original FASTQ files, straight from the sequencer, held at ENA. Large, and you align them yourself, so only choose this if you need to re-process the study from scratch.
What the files usually look like: For RNA-seq the counts are usually a table among the supplementary files (look for 'counts', 'expression', 'FPKM' or 'TPM' in the file name). The series matrix of a sequencing study is sometimes nearly empty.
Also filed as BioProject PRJNA1450390 and SRA study SRP690064. Searching any of these in the dataset finder brings you back here.
Supports a between-group comparison across 24 samples.
How we read this: 8 replicated groups read from 24 sample titles; they account for 24 of them. These groups are guessed from the sample names, not taken from the paper, so check them against the sample list below before relying on them.
- GSM9653203 SUDHL4_DMSO_Rep1 SUDHL4_DMSO
- GSM9653204 SUDHL4_DMSO_Rep2 SUDHL4_DMSO
- GSM9653205 SUDHL4_DMSO_Rep3 SUDHL4_DMSO
- GSM9653206 SUDHL4_DOT1Li_Rep1 SUDHL4_DOT1Li
- GSM9653207 SUDHL4_DOT1Li_Rep2 SUDHL4_DOT1Li
- GSM9653208 SUDHL4_DOT1Li_Rep3 SUDHL4_DOT1Li
- GSM9653209 SUDHL4_GSK343_Rep1 SUDHL4_GSK343
- GSM9653210 SUDHL4_GSK343_Rep2 SUDHL4_GSK343
- GSM9653211 SUDHL4_GSK343_Rep3 SUDHL4_GSK343
- GSM9653212 SUDHL4_Combo_Rep1 SUDHL4_Combo
- GSM9653213 SUDHL4_Combo_Rep2 SUDHL4_Combo
- GSM9653214 SUDHL4_Combo_Rep3 SUDHL4_Combo
- GSM9653215 SUDHL10_DMSO_Rep1 SUDHL10_DMSO
- GSM9653216 SUDHL10_DMSO_Rep2 SUDHL10_DMSO
- GSM9653217 SUDHL10_DMSO_Rep3 SUDHL10_DMSO
- GSM9653218 SUDHL10_DOT1Li_Rep1 SUDHL10_DOT1Li
- GSM9653219 SUDHL10_DOT1Li_Rep2 SUDHL10_DOT1Li
- GSM9653220 SUDHL10_DOT1Li_Rep3 SUDHL10_DOT1Li
- GSM9653221 WSU-DLCL2_DMSO_Rep1 WSU-DLCL2_DMSO
- GSM9653222 WSU-DLCL2_DMSO_Rep2 WSU-DLCL2_DMSO
- GSM9653223 WSU-DLCL2_DMSO_Rep3 WSU-DLCL2_DMSO
- GSM9653224 WSU-DLCL2_DOT1Li_Rep1 WSU-DLCL2_DOT1Li
- GSM9653225 WSU-DLCL2_DOT1Li_Rep2 WSU-DLCL2_DOT1Li
- GSM9653226 WSU-DLCL2_DOT1Li_Rep3 WSU-DLCL2_DOT1Li
- GSE277665 DOT1L and EZH2 cooperatively repress PRC2 targets to maintain the GC B cell identity in DLBCL [RNA-seq] 48 samples same disease briefing · shares dot1l, dlbcl, maintain, identity, rna-seq
- GSE224867 RNA-seq analysis of DLBCL cell lines in response to chemotherapy 36 samples same disease briefing · shares dlbcl, rna-seq
- GSE231624 (1) Effect of KLHL6 loss on the transcriptome in DLBCL upon NOTCH ligand stimulation. (2) Effect of KLHL6 and NOTCH2 loss on the transcriptome in DLBCL. (3) Effect of DLBCL-associated NOTCH2 mutants on the transcriptome in DLBCL. 48 samples same disease briefing · shares dlbcl
- GSE252690 Increased CCL2/CCR2 axis in MYC/BCL2 double-expressor DLBCL promotes tumor progression by increasing M2 macrophages 28 samples same disease briefing · shares dlbcl
- GSE280799 Expression Data from DLBCL Cell Line U2932 (Parental, CDC-Treated, and CDC-Resistant) and 8 DLBCL Patient Samples (5 High CDC-Sensitive, 3 Low CDC-Sensitive) 20 samples same disease briefing · shares dlbcl
- GSE228738 HDAC7 is essential in early pre-germinal center formation and its deregulation is associated with DLBCL 12 samples same disease briefing · shares dlbcl
- GSE242115 Morusinol is a Potent Therapeutic Agent Against DLBCL II 12 samples same disease briefing · shares dlbcl
- GSE249466 Bendamustine combined with rituximab induces pyroptosis to shape an "immunologically hot" tumor microenvironment in DLBCL cells via the STING pathway 12 samples same disease briefing · shares dlbcl
Metadata from NCBI GEO, cached and refreshed periodically — the NCBI page above is authoritative. Downloads link straight to NCBI/ENA; nothing is proxied through BioTransfer.